Ascendis Pharma A/S announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary ...
Nasdaq Private Market LLC is publicly launching a proprietary pricing product for private companies, joining an increasingly competitive space for data on potential IPO candidates.
Alkermes PLC (NASDAQ:ALKS) reported strong growth in its proprietary product portfolio, with net sales reaching $273 million, reflecting an 18% year-over-year increase. Vivitrol net sales grew by ...
Cambridge Cognition Addressing Inconsistencies in CNS Clinical Trials with Advanced Quality Review Solutions Presentation of new data demonstrates effectiveness of proprietary AQUA Cambridge Cognition ...